UHS · Universal Health Services Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted admissions (acute care, same facility basis) | 1.4% | first six months of 2026 | — |
| Adjusted admissions (behavioral health care, same facility basis) | 0.5% | second quarter of 2026 | — |
|
|
|||
| Adjusted EBITDA net of NCI non-GAAP | 1.33B | first six months of 2026 | — |
|
|
|||
| Adjusted patient days (acute care, same facility basis) | 1.9% | first six months of 2026 | — |
|
|
|||
| Adjusted patient days (behavioral health care, same facility basis) | 1.4% | second quarter of 2026 | — |
|
|
|||
| EBITDA net of NCI | 1.33B | first six months of 2026 | — |
|
|
|||
| Net revenue per adjusted admission (acute care, same facility basis) | 4.6% | first six months of 2026 | — |
| Net revenue per adjusted admission (behavioral health care, same facility basis) | 7.1% | second quarter of 2026 | — |
|
|
|||
| Net revenue per adjusted patient day (acute care, same facility basis) | 4.2% | first six months of 2026 | — |
|
|
|||
| Net revenue per adjusted patient day (behavioral health care, same facility basis) | 6.1% | second quarter of 2026 | — |
|
|
|||
| Net revenues (acute care services, same facility basis) | 8.2% | first six months of 2026 | — |
|
|
|||
| Net revenues (behavioral health care services, same facility basis) | 7.3% | first quarter of 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UHS
this stock
Universal Health Services Inc
|
$10.06B | -23.7% | +9.7% | 6.9 | 5.6% |
|
HCA
HCA Healthcare, Inc.
|
$92.77B | -10.3% | +7.1% | 14.4 | 2.6% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.63B | -11.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.19B | +32.2% | -2.3% | 13.4 | 3.5% |
|
DVA
Davita Inc.
|
$15.37B | +110.8% | +6.5% | 22.4 | 7.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UHS | +10.9% | +13.1% | -19.6% | +11.8% | -23.7% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | +11.9% | +13.1% | -27.1% | +12.6% | -32.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.